Clinical Trials Logo

Clinical Trial Summary

The understanding of pachychoroid phenotype is incomplete. It is important to understand the risk of conversion from an uncomplicated pachychoroid phenotype to the pachychoroid disease phenotype, to guide appropriate management of these patients.


Clinical Trial Description

The progression of uncomplicated pachychoroid phenotype to pachychoroid disease is not well established and the pathophysiology of these phenotypes remains unknown: specifically if the occurence of pachyvessels is the primary event, or develops secondary to the inner choroidal attenuation. A longitudinal study of the pachychoroid phenotype will provide much needed information regarding the natural history of the pachychoroid phenotype. Secondly, a detailed chronicle of the choroidal alterations in the pachychoroid disease spectrum may yield insights into the pathogenesis, and facilitate the development of disease modulation strategies. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04498000
Study type Observational [Patient Registry]
Source Singapore National Eye Centre
Contact
Status Completed
Phase
Start date July 22, 2020
Completion date November 30, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT06466018 - Research Into Diagnostic and Prognostic Molecular and Imaging Biomarkers of Ocular Disorders Associated With Neurovascular Deregulation: Biocor Cohort N/A